Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
PatientBase is the premier epidemiology database that provides robust coverage of more than 120 disease indications and more than 2000 patient populations... Learn More
Join us live on June 4, 2013... Learn More
View Webinar schedule and archive
See which reports have been searched on the most.
Visit Decision Resources Group at Booth 54 during the PBIRG Agency Fair on May 21 to meet our team, learn more about our best-in-class reports and services, and to demo our products.
Contact us to setup a meeting at PBIRG.
May 20, 2013
For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
May 14, 2013
In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
May 13, 2013
In Brazil, Mexico and Argentina, Dual Combination Therapy With Peg-IFN-alpha and Ribavirin Remains the Most Commonly Prescribed Treatment for all Hepatitis C Virus-Infected Patients
Argentina: Market Access Tracker
Last Updated 15 May 2013Argentina,
the fourth-largest pharmaceutical market in Latin America, and one of... Read More
Migraine (Event Driven)
Last Updated 13 May 2013All the currently
available triptan products, which constituted 70% of the migraine... Read More
Chronic Obstructive Pulmonary Disease
What Gains in Efficacy Will Be Necessary to Meet
Pulmonologist and Payer Expectations for Emerging LABA/LAMAs,... Read More